| MDL | MFCD00549245 |
|---|---|
| Molecular Weight | 210.28 |
| Molecular Formula | C9H18N6 |
| SMILES | CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 |
Altretamine is an alkylating antineoplastic agent.
Altretamine is an antineoplastic agent [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Altretamine (100, 133 mg/kg, ip.) in combination with Irofulven, increases the antitumor effect in mice bearing MV522 cells [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00002936 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Lymphoma|Sarcoma
|
July 1996 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 8.33 mg/mL ( 39.61 mM ; Need ultrasonic)
H 2 O : < 0.1 mg/mL (insoluble)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 4.7556 mL | 23.7778 mL | 47.5556 mL |
| 5 mM | 0.9511 mL | 4.7556 mL | 9.5111 mL |
| 10 mM | 0.4756 mL | 2.3778 mL | 4.7556 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 0.83 mg/mL (3.95 mM); Clear solution